Ramadan fasting and type 1 diabetes: a scoping review protocol.

Area of Science:

• Endocrinology and Metabolism
• Public Health
• Clinical Research

Background:

• Ramadan fasting is a widespread religious practice observed annually by millions worldwide.
• A significant number of individuals with type 1 diabetes observe Ramadan fasting, often with conflicting medical and religious guidance.
• There is a notable lack of comprehensive scientific evidence detailing the risks associated with Ramadan fasting for patients with type 1 diabetes.

Purpose of the Study:

• To systematically analyze and map the existing scientific literature on Ramadan fasting in patients with type 1 diabetes.
• To identify and highlight critical scientific gaps in the current body of research.
• To provide a foundation for future research and evidence-based guidelines.

Main Methods:

• A scoping review will be conducted using the Arksey and O'Malley framework, incorporating later amendments.
• Systematic searches of major databases (PubMed, Scopus, Embase) up to February 2022, supplemented by Persian and Arabic databases and grey literature.
• Rigorous screening and data extraction process involving multiple reviewers to ensure accuracy and resolve discrepancies.

Main Results:

• This section is to be populated upon completion of the review.
• The review will synthesize findings from diverse sources, including published studies, conference proceedings, and dissertations.
• Results will detail the identified risks, management strategies, and outcomes reported in the literature.

Conclusions:

• This scoping review will provide a comprehensive overview of the current evidence regarding Ramadan fasting in type 1 diabetes.
• It will identify key areas where further research is urgently needed to ensure patient safety and well-being.
• The findings will inform clinical practice and public health recommendations for managing type 1 diabetes during Ramadan.